Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
Age
51–90
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Subject has completed study 3133K1-3001 (Week 78) and brain magnetic resonance imaging (MRI) scan consistent with the diagnosis of Alzheimer Disease
Mini-Mental Status Examination (MMSE) \>=10 at screening
Caregiver able to attend all clinic visits with subject
You may not be if
Any medical or psychiatric contraindication or clinically significant abnormality that, in the investigator's judgment, will substantially increase the risk associated with the subject's participation in and completion of the study or could preclude the evaluation of the subject's response.
Any significant brain MRI abnormality.
Use of any investigational drugs or devices, other than bapineuzumab within the last 60 days prior to screening
